The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Johnson David Michael | Director | Grant(A) | 57K | — | $0 |
| Jun 16, 2026 | Skvarka Jan | Director | Grant(A) | 57K | — | $0 |
| Jun 16, 2026 | Walker Luke Nathaniel | Director | Grant(A) | 57K | — | $0 |
| Jun 16, 2026 | Kariuki Enoch | Director | Grant(A) | 57K | — | $0 |
| Jun 16, 2026 | Myers Scott Dunseth | Director | Grant(A) | 57K | — | $0 |
| Feb 10, 2026 | Vultaggio Vincent | PAO and PFO | Sell(S) | 7K | $2.42 | $17K |
| Feb 9, 2026 | Eastland Julia Marie | CEO & President, Director | Sell(S) | 889 | $2.39 | $2K |
| Feb 9, 2026 | Bruns Ingmar | Chief Medical Officer | Sell(S) | 335 | $2.39 | $801 |
| Feb 9, 2026 | Vultaggio Vincent | PAO and PFO | Sell(S) | 3K | $2.39 | $8K |
| Feb 6, 2026 | Eastland Julia Marie | CEO & President, Director | Sell(S) | 8K | $2.43 | $19K |
| Feb 6, 2026 | Bruns Ingmar | Chief Medical Officer | Sell(S) | 3K | $2.43 | $7K |
| Feb 6, 2026 | Vultaggio Vincent | PAO and PFO | Sell(S) | 30K | $2.43 | $73K |
| Feb 3, 2026 | Vultaggio Vincent | PAO and PFO | Sell(S) | 556 | $2.52 | $1K |
| Feb 2, 2026 | Vultaggio Vincent | PAO and PFO | Sell(S) | 3K | $2.55 | $6K |
| Jan 8, 2026 | Eastland Julia Marie | CEO & President, Director | Grant(A) | 775K | — | $0 |
| Jan 8, 2026 | Bucher James B | Chief Legal Officer | Grant(A) | 100K | — | $0 |
| Jan 8, 2026 | Bruns Ingmar | Chief Medical Officer | Grant(A) | 365K | — | $0 |
| Jan 8, 2026 | Vultaggio Vincent | PAO and PFO | Grant(A) | 100K | — | $0 |
| Dec 31, 2025 | Walters William Thurman | 10% Owner | Buy(P) | 6.5M | $1.20 | $7.8M |
| Dec 15, 2025 | Goel David E. | 10% Owner | Sell(S) | 7.5M | $1.33 | $10.0M |
| Oct 1, 2025 | Bucher James B | Chief Legal Officer | Grant(A) | 400K | — | $0 |
| Jun 17, 2025 | Myers Scott Dunseth | Director | Grant(A) | 58K | — | $0 |
| Jun 17, 2025 | Kariuki Enoch | Director | Grant(A) | 58K | — | $0 |
| Jun 17, 2025 | Johnson David Michael | Director | Grant(A) | 58K | — | $0 |
| Jun 17, 2025 | Skvarka Jan | Director | Grant(A) | 58K | — | $0 |
| Jun 17, 2025 | Walker Luke Nathaniel | Director | Grant(A) | 58K | — | $0 |
| Apr 30, 2025 | Myers Scott Dunseth | Director | Buy(P) | 21K | $1.40 | $29K |
| Feb 6, 2025 | Bruns Ingmar | Chief Medical Officer | Buy(P) | 20K | $2.28 | $46K |
| Feb 3, 2025 | Eastland Julia Marie | CEO & President, Director | Grant(A) | 59K | — | $0 |
| Feb 3, 2025 | Eastland Julia Marie | CEO & President, Director | Grant(A) | 59K | — | $0 |
| Feb 3, 2025 | Bruns Ingmar | Chief Medical Officer | Grant(A) | 17K | — | $0 |
| Feb 3, 2025 | Bruns Ingmar | Chief Medical Officer | Grant(A) | 17K | — | $0 |
| Feb 3, 2025 | Paul Andrea | Chief Legal Officer | Grant(A) | 934K | — | $0 |
| Feb 3, 2025 | Paul Andrea | Chief Legal Officer | Sell(S) | 13K | $1.71 | $23K |
| Feb 3, 2025 | Paul Andrea | Chief Legal Officer | Grant(A) | 125K | — | $0 |
| Feb 3, 2025 | Lackner Mark | Chief Scientific Officer | Grant(A) | 336K | — | $0 |
| Feb 3, 2025 | Lackner Mark | Chief Scientific Officer | Sell(S) | 14K | $1.71 | $25K |
| Feb 3, 2025 | Lackner Mark | Chief Scientific Officer | Grant(A) | 125K | — | $0 |
| Feb 3, 2025 | Vultaggio Vincent | PAO and Interim PFO | Grant(A) | 159K | — | $0 |
| Feb 3, 2025 | Vultaggio Vincent | PAO and Interim PFO | Sell(S) | 3K | $1.71 | $4K |
| Feb 3, 2025 | Vultaggio Vincent | PAO and Interim PFO | Grant(A) | 36K | — | $0 |
| Jan 31, 2025 | Eastland Julia Marie | CEO & President, Director | Buy(P) | 29K | $1.73 | $49K |
| Jan 31, 2025 | Walker Luke Nathaniel | Director | Buy(P) | 14K | $1.76 | $25K |
| Jan 31, 2025 | Skvarka Jan | Director | Buy(P) | 60K | $1.72 | $103K |
| Jan 2, 2025 | Lackner Mark | Chief Scientific Officer | Sell(S) | 4K | $3.12 | $14K |
| Dec 2, 2024 | Eastland Julia Marie | CEO & President, Director | Grant(A) | 3.0M | — | $0 |
| Dec 2, 2024 | Bruns Ingmar | Chief Medical Officer | Grant(A) | 713K | — | $0 |
| Nov 13, 2024 | Myers Scott Dunseth | Director | Grant(A) | 260K | — | $0 |
| Oct 4, 2024 | Vultaggio Vincent | Principal Accounting Officer | Sell(S) | 2K | $3.18 | $5K |
| Jun 21, 2024 | Johnson David Michael | Director | Grant(A) | 48K | — | $0 |
| Jun 21, 2024 | Kariuki Enoch | Director | Grant(A) | 42K | — | $0 |
| Jun 21, 2024 | Skvarka Jan | Director | Grant(A) | 42K | — | $0 |
| May 31, 2024 | Gallagher Cam | President, Interim CFO, Director | Sell(S) | 10K | $11.98 | $115K |
| May 24, 2024 | Walker Luke Nathaniel | Director | Grant(A) | 72K | — | $0 |
| May 9, 2024 | Hausman Diana | Chief Medical Officer | Sell(S) | 3K | $12.62 | $42K |
| Feb 12, 2024 | Gallagher Cam | President, Director | Sell(S) | 1K | $11.44 | $13K |
| Feb 12, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell(S) | 3K | $11.44 | $29K |
| Feb 2, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell(S) | 9K | $11.54 | $100K |
| Feb 2, 2024 | Gallagher Cam | President, Director | Sell(S) | 12K | $11.54 | $133K |
| Feb 2, 2024 | Paul Andrea | Chief Legal Officer | Sell(S) | 3K | $11.54 | $38K |
| Feb 2, 2024 | Lackner Mark | Chief Scientific Officer | Sell(S) | 2K | $11.54 | $18K |
| Feb 1, 2024 | Blackwell Kimberly | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Feb 1, 2024 | Blackwell Kimberly | Chief Executive Officer, Director | Tax withholding(F) | 21K | $11.69 | $241K |
| Feb 1, 2024 | Blackwell Kimberly | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Feb 1, 2024 | Epperly Melissa B, | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Feb 1, 2024 | Epperly Melissa B, | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Feb 1, 2024 | Gallagher Cam | President, Director | Grant(A) | 193K | — | $0 |
| Feb 1, 2024 | Gallagher Cam | President, Director | Grant(A) | 193K | — | $0 |
| Feb 1, 2024 | Paul Andrea | Chief Legal Officer | Grant(A) | 113K | — | $0 |
| Feb 1, 2024 | Paul Andrea | Chief Legal Officer | Grant(A) | 90K | — | $0 |
| Feb 1, 2024 | Paul Andrea | Chief Legal Officer | Grant(A) | 113K | — | $0 |
| Feb 1, 2024 | Lackner Mark | Chief Scientific Officer | Grant(A) | 141K | — | $0 |
| Feb 1, 2024 | Lackner Mark | Chief Scientific Officer | Grant(A) | 141K | — | $0 |
| Feb 1, 2024 | Hausman Diana | Chief Medical Officer | Grant(A) | 338K | — | $0 |
| Feb 1, 2024 | Hausman Diana | Chief Medical Officer | Grant(A) | 338K | — | $0 |
| Jan 2, 2024 | Lackner Mark | Chief Scientific Officer | Grant(A) | 40K | — | $0 |
| Jan 2, 2024 | Lackner Mark | Chief Scientific Officer | Grant(A) | 60K | — | $0 |
| Dec 20, 2023 | Bunker Kevin D. | Chief Scientific Officer | Gift(G) | 24K | — | $0 |
| Nov 13, 2023 | Blackwell Kimberly | Chief Executive Officer, Director | Buy(P) | 5K | $10.29 | $51K |
| Nov 10, 2023 | Johnson David Michael | Director | Buy(P) | 17K | $9.88 | $168K |
| Oct 4, 2023 | Brownstein Carrie | Chief Medical Officer | Sell(S) | 9K | $19.43 | $173K |
| Oct 4, 2023 | Brownstein Carrie | Chief Medical Officer | Sell(S) | 2K | $19.91 | $34K |
| Oct 4, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell(S) | 5K | $19.43 | $99K |
| Oct 4, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell(S) | 983 | $19.91 | $20K |
| Oct 4, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell(S) | 5K | $19.43 | $89K |
| Oct 4, 2023 | Epperly Melissa B, | Chief Financial Officer | Sell(S) | 888 | $19.91 | $18K |
| Sep 11, 2023 | Skvarka Jan | Director | Sell(S) | 5K | $25.05 | $125K |
| Jun 20, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy(P) | 4.8M | $22.66 | $107.9M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).